Research progress of immune checkpoint inhibitors in the treatment of glioblastoma

Research progress of immune checkpoint inhibitors in the treatment of glioblastoma

Glioblastoma (GBM) is the most invasive glioma in the central nervous system. Maximum surgical resection, chemotherapy and radiotherapy are currently the standard treatment for GBM. Due to the unique immune environment of the central nervous system, the application of immunotherapy in GBM is facing...

Full description

Saved in:
Bibliographic Details
Main Authors: JIA Xiaorong, ZHANG Gong
Format: Article
Language:zho
Published: Editorial Office of New Medicine 2024-05-01
Series:Yixue xinzhi zazhi
Subjects:
glioblastoma
immunotherapy
immunocyte
immune checkpoint inhibitors
Online Access:https://yxxz.whuznhmedj.com/futureApi/storage/attach/2406/o9E7MrjityHk2SeTlTyNYq8BAgyYODRSNIvoRLZ3.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items